DLBCL treatment options: CAR T outperforms ASCTNovember 3, 2023DLBCLCellular TherapyTransplantNon-Hodgkin Lymphoma
84-year-old MD contests employer’s mandatory cognitive tests for older docsNovember 1, 2023Business of Medicine
Ocular MALT lymphoma: Radiation reduces relapseOctober 26, 2023B Cell LymphomaIndolent LymphomaMixed Topics
Frontline myeloma treatments: ASCT vs. CAR TOctober 25, 2023Multiple MyelomaTransplantCellular Therapy
FDA OKs ivosidenib for IDH1-mutated myelodysplastic syndromesOctober 25, 2023Myelodysplastic Syndrome